ALFA News
Straight from the exchange filing
Latest Pharmaceuticals stock news from NSE and BSE filings, 95 stories so far.
Corona Remedies Ltd (CORONA) reported ₹422.43 Cr revenue for Q1 FY27, up 21.9% YoY. Management highlights 30.1% PAT growth and new hormonal facility commissioning.
Zydus Lifesciences launches REVAHALE, India's first once-daily nebulised LAMA for COPD, offering 24-hour relief. Company TTM revenue stands at 27,148.4 crores.
Alembic Pharmaceuticals reports 26% YoY revenue growth to INR 2,150 Cr in Q1 FY27, driven by US Generics. Management raises full-year growth guidance to mid-teens.
Kwality Pharmaceuticals reports 45.7% YoY revenue growth in Q1FY27 to ₹162.4 Cr. Management raises FY27 revenue guidance to ₹700+ Cr on strong export demand.
Gland Pharma signs a strategic CDMO partnership with a global pharmaceutical company for sterile injectables, projecting an annualized revenue of ₹902.5 Crore.
Amrutanjan Health Care commissions a ₹150 crore greenfield facility in Telangana with a 700 million unit capacity to boost its Comfy feminine hygiene brand.
Lupin Limited launches Sugammadex Injection in the US, a bioequivalent to Merck's Bridion® for surgical recovery, as the company reports 62.5% annual profit growth.
Sakar Healthcare reports 38% YoY revenue growth to ₹72.97 Cr in Q1 FY27, with net profit surging 120% to ₹10.28 Cr driven by high-margin oncology exports.
Gland Pharma launches USFDA-approved Sugammadex Injection vials, targeting a USD 1.6 billion US market for the reversal of surgical neuromuscular blockade now.
Jeena Sikho Lifecare (JSLL) launches four new Ayurvedic pain relief patches for domestic markets. The company reported 177% annual net profit growth in FY24.
RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combo for chronic pain. The pharmaceutical firm reported TTM revenue of ₹707.5 Cr.
Granules India secures Sole First-to-File ANDA status for Sodium Oxybate ER, the generic equivalent of LUMRYZ, targeting the US narcolepsy treatment market.
Zydus Lifesciences signs MoU with Apollo Hospitals to launch the Shield™ Multi-Cancer Detection test in India, targeting 10 cancer types via single blood draw.
Glenmark Pharmaceuticals initiates Phase 3 enrollment in India for Trastuzumab rezetecan, targeting ovarian cancer. TTM revenue stands at ₹16,982.51 Cr.
Zota Health Care adds 264 Davaindia stores in Q1FY27, bringing its total retail network to 2,825 stores as of June 30, 2026. Read the expansion details here.
Shilpa Medicare commissions an integrated ADC drug substance GMP facility in Dharwad, positioning it as a global CDMO partner with ₹11,561 Cr market valuation.
Shilpa Medicare commissions a state-of-the-art ADC GMP manufacturing facility in Dharwad. The new plant enhances CDMO capabilities in the oncology space.
Dr. Reddy's Laboratories launches generic Bosutinib Tablets 400mg in the U.S. with 180-day exclusivity, targeting a $253.8 million annual brand market size.
Jeena Sikho Lifecare (JSLL) commences operations at its 100-bed Ayurvedic hospital in Mathura, Uttar Pradesh, expanding its infrastructure to 60,000 sq. ft.
Wanbury Ltd expands global API reach with DMF submissions for Diphenhydramine HCl and Paroxetine HCl. Patalganga facility clears Korea MFDS audit with zero observations.
